Clinical Trial Update: A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

View source ↗

Summary

A completed post-approval study in Korea collecting safety and efficacy data for multiple myeloma patients treated with REVLIMID (lenalidomide). The study evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Status: COMPLETED